CagriSema
Unlock the potential of dual-hormone pathway research with our premium, pre-mixed Cagrilintide and Semaglutide peptide blend. This formula combines two clinically significant peptides into one vial, providing a powerful tool for investigating synergistic effects on appetite, satiety, and metabolism.
Our blend contains:
- Cagrilintide: A long-acting amylin analogue to study satiety signaling.
- Semaglutide: A potent GLP-1 receptor agonist to study appetite regulation.
This convenient, lyophilized blend is ideal for researchers studying next-generation obesity treatments. Each batch is rigorously tested for purity (≥99%) and identity, ensuring reliable and reproducible results for your experiments.
















Reviews
There are no reviews yet.